Literature DB >> 20064508

Episcleral clearance of sodium fluorescein from a bioerodible sub-tenon's implant in the rat.

Jessica E Chan1, Tiffany A Pridgen, Karl G Csaky.   

Abstract

We quantified episcleral drug clearance of sodium fluorescein (NaFl) in rats to examine the hypothesis that there is rapid clearance of episcleral water soluble drugs, and that this rapid clearance may limit the amount of drug that is able to reach the posterior segment from an episcleral location. 2 mm implants containing either 12 or 22 microg of NaFl were manufactured and in vitro release rates were determined. Implants were placed in the sub-Tenon's space and the amount of drug remaining in the conjunctiva/sclera/choroid complex (CSCC) at various time points was quantified following tissue solubilization and fluorescence quantification using a spectrofluorometer. Kinetics of NaFl clearance was determined in live animals, following euthanasia and in animals in which choroidal non-perfusion had been achieved with indocyanine green-enhanced 810 nm diode laser thrombosis of the choroidal vasculature. Choroidal non-perfusion in these laser-treated rats was verified with Concavalin-A staining of choroidal flatmounts. In vitro, >99% of drug was released by 25 min for the low dose implants, and by 60 min for the high dose implants. In vivo, both implant doses were >99% cleared from the episcleral tissue by 3 h. By 7 h, an average of only 0.14 +/- 0.131 ng of NaFl per mg of wet tissue weight (mean +/- SD) remained in the CSCC with the low dose implant, and 0.29 +/- 0.428 ng of NaFl per mg of wet tissue weight remained in animals with the high dose implant. By comparison, in euthanized animals at 7 h following sub-Tenon's implantation, 432.0 +/- 181.40 ng of NaFl per mg of wet tissue weight was in the episcleral tissue of animals with the low dose implant, and of 787.8 +/- 409.89 ng of NaFl per mg of wet tissue weight remained in the animals with the high dose implant. In live animals with selective thrombosis of the choroidal vasculature, the difference in the amount of drug remaining in the episcleral tissue as compared to control live animals was not significant at all time points for both implant doses. In conclusion, there is rapid clearance of episcleral NaFl delivered from a bioerodible sub-tenon's implant. The clearance mechanisms are dramatically reduced following euthanasia, suggesting that elimination is occurring via active physiologic mechanisms, rather than by passive diffusion clearance (CL(diff)) (Pfister et al., 2003). Interestingly, the choroid does not appear to play a prominent role as clearance of episcleral NaFl was not affected by elimination of choroidal blood flow. Further work is needed to delineate the pathways of episcleral drug clearance. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  animal model; drug delivery; episcleral lymphatics; sodium fluorescein

Mesh:

Substances:

Year:  2010        PMID: 20064508      PMCID: PMC2868259          DOI: 10.1016/j.exer.2010.01.001

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  24 in total

1.  Physicochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea.

Authors:  I Ahmed; R D Gokhale; M V Shah; T F Patton
Journal:  J Pharm Sci       Date:  1987-08       Impact factor: 3.534

Review 2.  Risks of intravitreous injection: a comprehensive review.

Authors:  Rama D Jager; Lloyd Paul Aiello; Samir C Patel; Emmett T Cunningham
Journal:  Retina       Date:  2004-10       Impact factor: 4.256

3.  Diffusion and flow transfer of theophylline across the blood-brain barrier: pharmacokinetic analysis.

Authors:  M D Karol; P Veng-Pedersen; R E Brashear
Journal:  J Pharmacokinet Biopharm       Date:  1983-06

4.  Diffusion across the sclera.

Authors:  D M Maurice; J Polgar
Journal:  Exp Eye Res       Date:  1977-12       Impact factor: 3.467

5.  Contribution of lymphatic drainage system in corneal allograft rejection in mice.

Authors:  F Hoffmann; E P Zhang; A Mueller; F Schulte; H D Foss; J Franke; S E Coupland
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-11       Impact factor: 3.117

Review 6.  Transscleral drug delivery for posterior segment disease.

Authors:  D H Geroski; H F Edelhauser
Journal:  Adv Drug Deliv Rev       Date:  2001-10-31       Impact factor: 15.470

7.  Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging.

Authors:  Hyuncheol Kim; Michael R Robinson; Martin J Lizak; Ginger Tansey; Robert J Lutz; Peng Yuan; Nam S Wang; Karl G Csaky
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-08       Impact factor: 4.799

8.  Modeling of transfer kinetics at the serum-cerebrospinal fluid barrier in rabbits with experimental meningitis: application to grepafloxacin.

Authors:  Marc Pfister; Liping Zhang; Margareta Hammarlund-Udenaes; Lewis B Sheiner; Cynthia M Gerber; Martin G Täuber; Philippe Cottagnoud
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

9.  Permeability of human cornea and sclera to sulfonamide carbonic anhydrase inhibitors.

Authors:  H F Edelhauser; T H Maren
Journal:  Arch Ophthalmol       Date:  1988-08

10.  Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.

Authors:  Esther Furrer; Marianne Berdugo; Cinzia Stella; Francine Behar-Cohen; Robert Gurny; Ulrich Feige; Peter Lichtlen; David M Urech
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-29       Impact factor: 4.799

View more
  1 in total

1.  Efficacy of Sub-Tenon Micro-Perfusion of Cyclophosphamide in Rabbits with Severe Ocular Inflammation.

Authors:  Libei Zhao; Manqiang Peng; Wenxiang Lin; Qian Tan; Muhammad Ahmad Khan; Ding Lin
Journal:  Drug Des Devel Ther       Date:  2020-08-20       Impact factor: 4.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.